Log in to save to my catalogue

JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key...

JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_884853d979524cb0baaf96a8fa01dba1

JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component

About this item

Full title

JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component

Publisher

England: BioMed Central Ltd

Journal title

Molecular cancer, 2017-11, Vol.16 (1), p.175-175, Article 175

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Melanoma, originated from melanocytes located on the basal membrane of the epithelial tissue, is the most aggressive form of skin cancer that accounts for 75% of skin cancer-related death. Although it is believed that BRAF mutation and the mitogen-activated protein kinase (MAPK) pathway play critical roles in the pathogenesis of melanoma, how the M...

Alternative Titles

Full title

JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_884853d979524cb0baaf96a8fa01dba1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_884853d979524cb0baaf96a8fa01dba1

Other Identifiers

ISSN

1476-4598

E-ISSN

1476-4598

DOI

10.1186/s12943-017-0744-2

How to access this item